Antisense & RNAi Technology Market Research Reports & Industry Analysis
Antisense and RNAi technology has the potential to influence gene expression, offering new possibilities for treating previously challenging diseases. Staying informed about this evolving field is crucial, and MarketResearch.com's reports on the antisense and RNAi technology industry are valuable resources. These reports offer in-depth analyses of industry trends, challenges, and opportunities to help stakeholders make well-informed decisions based on accurate information.
Comprehensive Antisense and RNAi Technology Research
- Find research on a wide spectrum of key market segments including reagents, consumables, RNAi drug delivery, and RNAi therapeutics.
- Gain a holistic view of the industry by delving into RNAi market sizing, growth trajectories, technological breakthroughs, and competitor strategies.
- Understand the trends that are shaping the antisense and RNAi technology industry to stay ahead of the curve in an environment characterized by change.
Why Choose MarketResearch.com
Whether you're a busy executive or a professional in the field, our antisense and RNAi technology market research reports are designed to meet your information needs. These reports offer reliable data to support your business decisions and help you take advantage of emerging market opportunities. Embrace the value of knowledge and confidently explore the potential of the antisense and RNAi technology industry with MarketResearch.com.
Antisense & RNAi Technology Industry Research & Market Reports
-
RNAi Drug Delivery Market Size, Trends, Analysis, and Outlook By Technology (Nanoparticle drug delivery, Pulmonary drug delivery, Nucleic acid drug delivery, Aptamer drug delivery), By Application (Infectious diseases, Oncology, Cardiology, Neurology, Others), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global RNAi Drug Delivery market size is poised to register 17.5% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
Antisense and RNAi Therapeutics Market Size, Trends, Analysis, and Outlook By Technology (RNA Interference, Antisense RNA), By Application (Ocular, Cardiometabolic & Renal Disorders, Cancer, Respiratory Disorders, Skin Diseases, Neurodegenerative Disorders, Genetic Disorders, Infectious Diseases, Others), By Route of Administration (Intravenous Injections, Intrathecal Injections, Subcutaneous Injections, Others), by Region, Country, Segment, and Companies, 2024-2030
... By Route of Administration (Intravenous Injections, Intrathecal Injections, Subcutaneous Injections, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Antisense and RNAi Therapeutics market size is poised to register 9.24% growth from 2024 to ... Read More
-
Viral Vectors and Plasmid DNA Manufacturing Market Size, Trends, Analysis, and Outlook By Type (Adenovirus, Retrovirus, Adeno-Associated Virus (AAV), Lentivirus, Plasmids, Others), By Manufacturing (Upstream Manufacturing (Vector Amplification & Expansion, Vector Recovery/Harvesting), Downstream Manufacturing (Purification, Fill Finish)), By Application (Antisense & RNAi Therapy, Gene Therapy, Cell Therapy, Vaccinology, Research Applications), By End-user (Pharmaceutical and Biopharmaceutical Companies, Research Institutes), By Disease (Cancer, Genetic Disorders, Infectious Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030
... Fill Finish)), By Application (Antisense & RNAi Therapy, Gene Therapy, Cell Therapy, Vaccinology, Research Applications), By End-user (Pharmaceutical and Biopharmaceutical Companies, Research Institutes), By Disease (Cancer, Genetic Disorders, Infectious Diseases, Others), by Region, Country, Segment, ... Read More
-
Viral Vector Contract Development Manufacturing Organizations Market Size, Trends, Analysis, and Outlook By Vector (Adenovirus, Retrovirus, Adeno-Associated Virus, Lentivirus, Others), By Workflow (Upstream Manufacturing, Downstream Manufacturing), By Application (Antisense & RNAi Therapy, Gene Therapy-, Cell Therapy, Vaccinology, Research Applications), By End-user (Pharmaceutical & Biopharmaceutical Companies, Research Institutes), by Region, Country, Segment, and Companies, 2024-2030
... Therapy, Vaccinology, Research Applications), By End-user (Pharmaceutical & Biopharmaceutical Companies, Research Institutes), by Region, Country, Segment, and Companies, 2024-2030 The global Viral Vector Contract Development Manufacturing Organizations market size is poised to register 14.5% growth ... Read More
-
RNA Therapy Clinical Trials Market Size, Trends, Analysis, and Outlook By Modality (RNA interference, Antisense therapy, Messenger RNA, Oligonucleotide, non-antisense, non-RNAi), By Phase (Phase I, Phase II, Phase III, Phase IV), By Therapeutic Area (Rare Diseases, Anti-infective, Anticancer, Neurological, Alimentary/Metabolic, Musculoskeletal, Cardiovascular Respiratory, Sensory, Others), by Region, Country, Segment, and Companies, 2024-2030
... Diseases, Anti-infective, Anticancer, Neurological, Alimentary/Metabolic, Musculoskeletal, Cardiovascular Respiratory, Sensory, Others), by Region, Country, Segment, and Companies, 2024-2030 The global RNA Therapy Clinical Trials market size is poised to register 6.14% growth from 2024 to 2030, ... Read More
-
The 2025-2030 World Outlook for RNAi Technologies
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for RNAi Therapies
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Antisense and RNAi Therapeutics
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for RNAi Drug Deliveries
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for RNA Interference (RNAi) Technologies
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Drug Discovery and Development RNA Interference (RNAi)
... estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. ... Read More
-
The 2025-2030 World Outlook for RNAi Therapeutics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
Biologics Market Report by Source (Microbial, Mammalian, and Others), Product (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense, RNAi and Molecular Therapy, and Others), Disease (Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, and Others), Manufacturing (Outsourced, In-House), and Region 2024-2032
... and Region 2024-2032 The global biologics market size reached US$ 349.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 699.5 Billion by 2032, exhibiting a growth rate (CAGR) of 7.8% ... Read More
-
Antisense and RNAi Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Technology (Antisense RNA and RNA Interference); By Route of Administration; By Application; By Region; Segment Forecast, 2024 - 2032
... RNAi therapeutics market size is expected to reach USD 18.43 billion by 2032, according to a new study by Polaris Market Research. The report “Antisense and RNAi Therapeutics Market Share, Size, Trends, Industry Analysis Report, ... Read More
-
Global RNAi Technologies Market Growth (Status and Outlook) 2024-2030
... downstream market, the RNAi Technologies is forecast to a readjusted size of US$ 414.1 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global ... Read More
-
Antisense & RNAi Therapeutics Global Market Report 2024
... Disorders; Infectious Diseases Covering: Biogen Inc.; Ionis Pharmaceuticals Inc.; Alnylam Pharmaceuticals Inc.; Arrowhead Pharmaceuticals Inc.; Moderna Inc. Antisense & RNAi Therapeutics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior ... Read More
-
Global Antisense and RNAi therapeutics Market Size study & Forecast, by Technology (RNA Interference, Antisense RNA) by Application (Genetic Disease, Cancer, Infectious Disease, Neurodegenerative Disorders, Cardiometabolic & Renal Disorders, Ocular Disorders, Respiratory Disorders, Skin Disorders), by Route of Administration (Intravenous Injections, Intrathecal Injections, Subcutaneous Injections, Other Delivery Methods), and Regional Analysis, 2023-2030
... by Route of Administration (Intravenous Injections, Intrathecal Injections, Subcutaneous Injections, Other Delivery Methods), and Regional Analysis, 2023-2030 Global Antisense and RNAi therapeutics Market is valued approximately at USD 3.69 billion in 2022 and is anticipated ... Read More
-
Global RNA-interference (RNAi) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... 2.9 billion by 2029, growing at a CAGR of 16.29% during the forecast period (2024-2029). COVID-19 is expected to have a significant impact on the growth of the market. The demand for RNA interference is ... Read More
-
Global Antisense & RNAi Therapeutics Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... market growth of the Antisense & RNAi Therapeutics industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Antisense & RNAi Therapeutics. The report ... Read More
-
Antisense & RNAi Therapeutics Market Forecasts to 2030 – Global Analysis By Route of Administration (Subcutaneous Route, Intravenous Route, Pulmonary Delivery, Intrathecal Route, Intraperitoneal Injection and Other Routes of Administration), Indication (Autosomal Dominant Disease, Autosomal Recessive Disease, Chromosomal Disease and Other Indications), Technology, Application and By Geography
... Recessive Disease, Chromosomal Disease and Other Indications), Technology, Application and By Geography According to Stratistics MRC, the Global Antisense & RNAi Therapeutics Market is accounted for $1.66 billion in 2023 and is expected to reach ... Read More
-
Genome Editing Market by Technology (Antisense, CRISPR, Talen), Application (Cell Line Engineering, Genetic Engineering), End User - Global Forecast 2024-2030
... to reach USD 16.54 billion in 2024, at a CAGR 53.22% to reach USD 214.22 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Genome Editing Market. It offers ... Read More
-
Antisense & RNAi Therapeutics Market by Technology (Antisense RNA, RNA Interference), Application (Cardiovascular Diseases (CVDs), Genetic Disorders, Infectious Diseases), Route of Administration - Global Forecast 2024-2030
... at USD 4.51 billion in 2023 and expected to reach USD 4.93 billion in 2024, at a CAGR 9.34% to reach USD 8.43 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Gene Editing Technologies Market by Offering (Reagents & Consumables, Services, Software & Systems), Technology (Antisense, CRISPR, Talen), Application, End User - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 5.73 billion in 2024, at a CAGR 12.57% to reach USD 11.74 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Global Antisense & RNAi Therapeutics Market
... By Route of Administration (Intravenous Injections, Intrathecal Injections, Subcutaneous Injections and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) Antisense & RNAi therapeutics refer to a class of drugs ... Read More
-
RNAi Drug Delivery Market Report: Trends, Forecast and Competitive Analysis to 2030
... cardiology, oncology, neurology, ophthalmology, urology, and metabolic disorder markets. The global RNAi drug delivery market is expected to reach an estimated $3.5 billion by 2030 with a CAGR of 20.5% from 2024 to 2030. The ... Read More
Research Assistance
